RecruitingNCT07146854
EndoForce Post Approval Study
Sponsor
Phraxis, Inc.
Enrollment
150 participants
Start Date
Jan 13, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Patient is ≥18 years of age.
- Patient requires the creation of a vascular access graft for hemodialysis, secondary to a diagnosis of ESRD.
- Patient is able to have the vascular access ePTFE graft placed in an upper arm.
- Patient or his/her legal guardian understands the study and is willing and able to comply with the dialysis schedule and follow-up requirements.
- Patient or his/her legal guardian provides written informed consent.
Exclusion Criteria3
- All contraindications for the EndoForce Connector System according to the IFU.
- Patient is pregnant.
- Patient is enrolled in another dialysis or vascular investigational study, without prior approval from the Sponsor.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07146854
Related Trials
Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients
NCT071573971 location
Pivotal Study of the Velocity™ pAVF System
NCT0715393910 locations
A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial
NCT073611461 location
Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
NCT073485361 location
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
NCT0467177121 locations